Sign inJoin waitlistJoin the waitlist

Ali Nabavizadeh

Director, Alternate Fellowship Pathway to Board Certification · Perelman School of Medicine at the University of Pennsylvania

Credentials: · · · · · ·

History

University of Pennsylvania Health System · Perelman School of Medicine at the University of Pennsylvania
Present

Nuclear Radiology
Hospital of the University of Pennsylvania
2013–2014
Neuroradiology
Hospital of the University of Pennsylvania
2012–2013
Children's Hospital of Philadelphia
2011–2012
Shiraz University of Medical Sciences
2008–2011
Sea Mar Olympia Medical Clinic
2004–2008
Preliminary or Transitional Year
2003–2004
SHIRAZ UNIV OF MED SCI & HLTH SERV, MED SCH, SHIRAZ, IRAN
1999–2003

Research

Intrathecal bivalent CAR T cells targeting EGFR and IL13Rα2 in recurrent glioblastoma: phase 1 trial interim results
Nature Medicine · 2024 · 336 citations
Synergistic immunotherapy of glioblastoma by dual targeting of IL-6 and CD40
Nature Communications · 2021 · 128 citations
Clinical Utility of Plasma Cell-Free DNA in Adult Patients with Newly Diagnosed Glioblastoma: A Pilot Prospective Study
Clinical Cancer Research · 2020 · 106 citations

Arastoo Vossough
40 papers
Phillip Storm
23 papers
Jeffrey Ware
21 papers
Sabine Mueller
21 papers
Stephen Bagley
19 papers
Mariam Aboian
17 papers · 1 as a fellow
Benjamin Kann
16 papers · 16 as a resident
HA
Hannah Anderson
16 papers · 13 as a resident
Donald O’Rourke
15 papers
Arati Desai
14 papers
Sina Bagheri
14 papers · 2 as a resident
Suyash Mohan
14 papers

Clinical trials

Multimodality MRI and Liquid Biopsy in GBM
Principal investigator · Withdrawn · Early phase 1
Abramson Cancer Center at Penn Medicine
2022
Pilot Study of 18F-FMISO PET/CT and MRI Imaging to Explore Tissue Hypoxia and Arteriovenous Shunting in Subjects With Recurrent Glioblastoma Before and After Bevacizumab Treatment
Principal investigator · Terminated · Phase 1
Abramson Cancer Center at Penn Medicine
2018–2020